Cutaneous leishmaniasis in the Middle East

Clinics in Dermatology

Volumn 17, Issue 2, 1999, Pages 137-141

  Klaus, Sidney ^a   Frankenburg, Shoshana ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; LEISHMANIA VACCINE; LIQUID NITROGEN; MEGLUMINE ANTIMONATE; METHYLBENZETHONIUM CHLORIDE; PAROMOMYCIN;

ARTICLE; CLINICAL FEATURE; HIGH RISK POPULATION; HUMAN; MIDDLE EAST; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; PSYCHODIDAE; SKIN LEISHMANIASIS; VACCINATION;

EID: 0032755432     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00006-1     Document Type: Review

References (29)

1. Gelpi A. Alexander Russell and the Aleppo ulcer. Int J Dermatol. 26:1987;131-134.
2. Plumbe S. A practical treatise on the diseases of the skin. 1837;584-585 Sherwood, Gilbert & Piper, London.
3. Desjeux P. Information on the epidemiology and control of the leishmaniases by country and territory. 1991;World Health Organization, Geneva.
4. Saliba E., Saleh N., Bishart Z., et al. Cutaneous leishmaniasis due to Leishmania tropica in Jordan. Trans Roy Soc Trop Med Hyg. 87:1993;633.
5. Klaus S., Axelrod O., Jonas F., et al. Changing patterns of cutaneous leishmaniasis in Israel and neighboring territories. Trans Roy Soc Trop Med Hyg. 88:1994;649-650.
6. Alvarado R., Enk C., Jaber K., et al. Delayed-type sensitivity and lymphocyte proliferation in response to Leishmania major infection in a group of children in Jericho. Trans Roy Soc Trop Med Hyg. 83:1989;189-192.
7. Al-Gindan Y., Abdul-Aziz O., Kubba R. Cutaneous leishmaniasis in Al-Hassa, Saudi Arabia. Int J Dermatol. 23:1984;194-197.
8. Frayauff D., Modi G., Mansour N., et al. Epidemiology of cutaneous leishmaniasis at a focus monitored by the Multinational Force and Observers in the northeastern Sinai desert of Egypt. Am J Trop Med Hyg. 49:1993;598-607.
9. Tayeh A., Jalouk L., Cairncross S. Twenty years of cutaneous leishmaniasis in Aleppo, Syria. Trans Roy Soc Trop Med. 91:1997;657-659.
10. Melby P., Kreutzer R., McMahon-Pratt D., et al. Cutaneous leishmaniasis Review of 59 cases seen at the National Institutes of Health . J Infect Dis. 15:1992;924-937.
11. Giladi M., Danon Y., Greenblatt C., et al. Local environmental risk factors in the acquisition of cutaneous leishmaniasis. Isr J Med Sci. 24:1988;185-187.
12. Al-Gindan Y., Kubba R., El-Hassan A., et al. Dissemination in cutaneous leishmaniasis. Int J Dermatol. 28:1989;248-254.
13. Vardy D., Frankenburg S., Goldenhersh M., et al. Unusually extensive disease caused by Leishmania major parasites. Clin Exp Dermatol. 18:1993;36-40.
14. Satti M., El-Hassan A., Al-Gindan Y., et al. Peripheral neural involvement in cutaneous leishmaniasis. Int J Dermatol. 28:1989;243-247.
15. Kubba R., El-Hassan A., Al-Gindan Y., et al. Dissemination in cutaneous leishmaniasis. Int J Dermatol. 26:1987;300-304.
16. Gillis D., Klaus S., Schnur L., et al. Diffusely disseminated cutaneous Leishmania major infection in a child with acquired immunodeficiency syndrome. Ped Infect Dis J. 14:1995;247-249.
17. Momeni A., Aminjavaheri M. Treatment of recurrent cutaneous leishmaniasis. Int J Dermatol. 34:1995;129-133.
18. Control of the leishmaniases. 1990;World Health Organization, Geneva.
19. Schlein Y., Jacobson R. Mortality of Leishmania major in Phlebotomus papatasi caused by plant feeding of the sand flies. Am J Trop Med Hyg. 50:1994;20-27.
20. Yaghoobi-Ershad M., Akhavan A., Mohebali M. Meriones libycus and Rhombomys opimus (Rodentia Gerbillidae) are the main reservoir hosts in a new focus of zoonotic cutaneous leishmaniasis in Iran . Trans Roy Soc Trop Med Hyg. 90:1996;503-504.
21. Kamhawi S., Arbagi A., Adwan S., et al. Environmental manipulation in the control of a zoonotic cutaneous leishmaniasis focus. Arch Inst Pasteur Tunis. 70:1993;383-390.
22. Ashford R. Leishmaniasis reservoirs and their significance in control. Clin Dermatol. 14:1996;523-532.
23. Al-Majali O., Routh H., Abuloham O., et al. A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. Int J Dermatol. 36:1997;460-462.
24. Ozgoztasi O., Kirtak N., Erbagci Z. Cryotherapy in the treatment of cutaneous leishmaniasis. J Dermatol Treat. 8:1997;179-182.
25. El-On J., Halevy S., Grunwald M., et al. Topical treatment of Old World cutaneous leuishmaniasis caused by Leishmania major. A double-blind control study. J Am Acad Dermatol. 27:1992;227-231.
26. Ozgoztasi O., Baydar I. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey. Int J Dermatol. 36:1997;61-63.
27. Modabber F. Vaccines against leishmaniasis. Ann Trop Med Parasit. 89:1995;83-88.
28. Frankenburg S., Axelrod O., Kutner S., et al. Effective immunization of mice against cutaneous leishmaniasis using an intrinsically adjuvanted synthetic lipopeptide vaccine. Vaccine. 14:1996;923-929.
29. Xu D., Liew F. Protection against leishmaniasis by injection of DNA encoding a major surface lipoprotein, gp63, of L. major. Immunology. 84:1995;173-176.